Psyence Biomedical Valuation
| PBM Stock | USD 3.51 0.17 5.09% |
At this time, the company appears to be overvalued. Psyence Biomedical holds a recent Real Value of $3.37 per share. The prevailing price of the company is $3.51. Our model determines the value of Psyence Biomedical from analyzing the company fundamentals such as Shares Owned By Insiders of 58.48 %, net income of (51.16 M), and Return On Asset of -1.26 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Psyence Biomedical's valuation include:
Enterprise Value 12.3 M |
Overvalued
Today
Please note that Psyence Biomedical's price fluctuation is dangerous at this time. Calculation of the real value of Psyence Biomedical is based on 3 months time horizon. Increasing Psyence Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Psyence stock is determined by what a typical buyer is willing to pay for full or partial control of Psyence Biomedical Ltd. Since Psyence Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Psyence Stock. However, Psyence Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.51 | Real 3.37 | Hype 4.32 | Naive 3.98 |
The intrinsic value of Psyence Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Psyence Biomedical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Psyence Biomedical Ltd helps investors to forecast how Psyence stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Psyence Biomedical more accurately as focusing exclusively on Psyence Biomedical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Psyence Biomedical's intrinsic value based on its ongoing forecasts of Psyence Biomedical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Psyence Biomedical's closest peers.
Psyence Biomedical Cash |
|
Psyence Valuation Trend
Knowing Psyence Biomedical's actual value is paramount for traders when making sound investment determinations. Using both Psyence Biomedical's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Psyence Biomedical Total Value Analysis
Psyence Biomedical Ltd is at this time forecasted to have company total value of 12.32 M with market capitalization of 2.6 M, debt of 10.45 M, and cash on hands of 281.63 K. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Psyence Biomedical fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
12.32 M | 2.6 M | 10.45 M | 281.63 K |
Psyence Biomedical Asset Utilization
One of the ways to look at asset utilization of Psyence is to check how much profit was generated for every dollar of assets it reports. Psyence Biomedical holds a negative application of assets of -1.26 pct., losing $0.0126 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Psyence Biomedical Ltd shows how discouraging it operates for each dollar spent on its assets.Psyence Biomedical Ownership Allocation
Psyence Biomedical owns a total of 16.7 Million outstanding shares. Psyence Biomedical has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Psyence Biomedical Profitability Analysis
Reported Net Loss for the year was (51.16 M) with profit before taxes, overhead, and interest of 0.About Psyence Biomedical Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Psyence Biomedical Ltd. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Psyence Biomedical based exclusively on its fundamental and basic technical indicators. By analyzing Psyence Biomedical's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Psyence Biomedical's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Psyence Biomedical. We calculate exposure to Psyence Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Psyence Biomedical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | (216.00) | (226.80) |
Psyence Biomedical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Psyence Biomedical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 6.5 M |
Psyence Biomedical Current Valuation Indicators
Psyence Biomedical's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Psyence Biomedical's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Psyence Biomedical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Psyence Biomedical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Psyence Biomedical's worth.When determining whether Psyence Biomedical is a strong investment it is important to analyze Psyence Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Psyence Biomedical's future performance. For an informed investment choice regarding Psyence Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Psyence Biomedical Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psyence Biomedical. If investors know Psyence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psyence Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.82) | Return On Assets (1.26) |
The market value of Psyence Biomedical is measured differently than its book value, which is the value of Psyence that is recorded on the company's balance sheet. Investors also form their own opinion of Psyence Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Psyence Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psyence Biomedical's market value can be influenced by many factors that don't directly affect Psyence Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psyence Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Psyence Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.